Search results
Panel rejects psychedelic drug MDMA as a PTSD treatment
NBC Washington· 4 days agoA panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of ...
FDA advisors' scrutiny of MDMA therapy is 'temporary setback,' says Harvard researcher
WBUR Boston· 2 days agoThe researchers said the decision by advisors to the U.S. Food and Drug Administration reflected...
Panel rejects psychedelic drug MDMA as treatment for PTSD
Anchorage Daily News· 3 days agoA panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of ...
What Is MDMA Therapy and What Are Its Risks?
New York Times· 4 days agoThe Food and Drug Administration is weighing whether to approve the use of MDMA, also known as Ecstasy, for treatment of post-traumatic stress disorder....
Lykos' MDMA treatment rejected by FDA committee, despite being '75% of the way there'
FierceBiotech· 3 days agoLykos Therapeutics’ attempt to get the first ever MDMA treatment approved in post-traumatic stress...
‘Dead wrong’: Lawmakers, advocates decry rejection of MDMA-assisted therapy by FDA panel
The Hill via AOL· 2 days agoA Food and Drug Administration (FDA) panel’s surprising recommendation this week to reject the use...
FDA advisers reject MDMA therapy to treat PTSD
FOX 10 Phoenix· 3 days agoFood and Drug Administration advisers voted to reject using MDMA as a treatment for post-traumatic stress disorder. Panel members on Tuesday also pointed...
The Download: MDMA for PTSD, and Boeing’s rearranged space flight
Technology Review· 5 days agoMDMA has been banned in the United States for more than three decades. On June 4, the Food and Drug...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
Las Vegas Sun· 4 days agoA panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of MDMA when used to treat post-traumatic stress disorder. “It seems
Flawed, scandalous trials tank FDA expert support for MDMA therapy
Ars Technica· 4 days agoAfter a remarkably sensational regulatory drug review, advisers for the Food and Drug Administration...
